フラクトオリゴ糖の世界市場 2023年～2030年

概要

フラクトオリゴ糖の世界市場は、2022年に32億1,000万米ドルに達し、2023年から2030年にかけてCAGR 8.1%で成長し、2030年には59億9,000万米ドルに達すると予測されています。

フラクトオリゴ糖は甘味強度が低く、非カリ原性で、水溶性食物繊維として使用されます。この製品は低カロリーであるため、乳児用製剤、飲食品、栄養補助食品、動物飼料、医薬品など、食品・非食品分野のさまざまなカテゴリーで砂糖の代替品として利用されています。本製品は、液体や固体の形態で入手可能であり、必要な製品に便利かつ効果的に応用できます。

製品の様々な機能的利点は、より多くの生産に対する製品需要を促進します。製品製造におけるメーカーの持続可能な慣行の採用は、世界レベルでの市場の積極的な拡大をもたらしています。メーカー各社は、低エネルギー原単位と廃水ゼロという持続可能性へのコミットメントの一環として、グリーンケミストリーに投資しています。例えば、TATA Chemicals Limitedは、砂糖からフラクトオリゴ糖を製造する技術である発酵プラットフォームを開発しました。

市場の成長を支配したのは北米です。CDCによると、約3,730万人の米国人が糖尿病に苦しんでおり、米国人口の約11.3％を占めています。生活習慣病の有病率の増加は消費者の健康意識を高め、北米における砂糖代替品のニーズを促進し、市場成長にプラスの影響を与えています。

市場力学

フラクトオリゴ糖の機能的利点

フラクトオリゴ糖は非カリ原性で、水溶性食物繊維として使用されます。水溶性食物繊維の優れた供給源であり、便秘の軽減または解消を促進します。また、食中毒に関連する有害細菌を抑制することで、消化管内の健康な細菌の増殖をサポートします。

フラクトオリゴ糖は難消化性で、そのまま小腸を通過して大腸に至り、そこで消化管の健康維持に役立つ健康な細菌の増殖をサポートします。フラクトオリゴ糖はプレバイオティクスサプリメントの原料として使用されています。フラクトオリゴ糖は、ミネラルの吸収を改善するなどの有益な生理学的効果があります。

代替糖としてのフラクトオリゴ糖の高い利用率

世界保健機関（WHO）の2022年の統計によると、世界で10億人以上が肥満に苦しんでおり、6億5,000万人が成人、3億4,000万人が青少年です。WHOの2022年の統計によると、肥満の深刻さは子供にも増加しており、最大3,900万人を占めています。

IDF糖尿病アトラス2021によると、世界で5億3,700万人の成人が糖尿病を患っています。同団体の報告によると、有病率は急速に増加しており、2030年には6億4,300万人に達すると推定されています。高カロリー摂取による肥満と糖尿病の世界の有病率の増加に伴い、低カロリーの代替甘味料の必要性が高まっています。

フラクトオリゴ糖は、主に低カロリーの代替甘味料として使用されています。繊細な甘味でカロリーが低く、ショ糖の半分以下のカロリーしかありません。フラクトオリゴ糖は難消化性で、血糖値に影響を与えません。これらは代替糖として様々な食品用途に使用され、市場の成長を牽引しています。

フラクトオリゴ糖の高コストと潜在的副作用

フラクトオリゴ糖の高コストは、世界市場成長の主要な抑制要因の一つとなり得る。低い収率、高い生産コスト、複雑な精製と品質管理は、フラクトオリゴ糖の高コストの要因のいくつかです。価格に敏感なエンドユーザーは、この製品を置き去りにして、より安価な他の砂糖代替品を取り上げる可能性があります。

フラクトオリゴ糖の過剰摂取は、下痢、腹部膨満感、胃痙攣などの副作用を引き起こす可能性があります。この副作用は、果糖不耐症に起因することもあります。多量摂取は胃の不調を招き、過敏性腸症候群の人々を苦しめます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • フラクトオリゴ糖の機能的利点
    • 代替糖としての高い利用
  • 抑制要因
    • フラクトオリゴ糖の高コストと副作用の可能性
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• DMIの見解

第6章 COVID-19分析

第7章 由来別

• スクロース
• イヌリン

第8章 形態別

• 液体
• 粉末

第9章 用途別

• 乳児用製剤
• 食品・飲料
• 栄養補助食品
• 動物飼料
• 医薬品

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• BENEO
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Cargill, Incorporated
• Ingredion
• Tereos
• Biosynth
• Tate & Lyle
• Galam Group
• TATA Chemicals Limited
• AVANSCHEM
• Merck KGaA

第13章 付録

Overview

Global Fructo-Oligosaccharides Market reached US$ 3.21 billion in 2022 and is expected to reach US$ 5.99 billion by 2030, growing with a CAGR of 8.1% during the forecast period 2023-2030.

Fructo-oligosaccharides have a low sweetness intensity, non-cariogenic and used as soluble dietary fibres. The low-calorie nature of the product drives its use as a sugar alternative for applications in various categories of food and non-food segments such as infant formulation, food & beverages, dietary supplements, animal feed and pharmaceuticals. The product is available in solid in liquid form or its convenient and effective application in required products.

Various functional benefits of the product drive the product demand for more production. The adoption of sustainable practices by manufacturers for product manufacturing is expanding the positive reach of the market at the global level. Manufacturers are investing in Green Chemistry as part of the sustainability commitment to low energy intensity and zero effluents. For instance, TATA Chemicals Limited developed a Fermentation Platform, a technology to produce fructo-oligosaccharides from sugar.

North America dominated the market growth. According to the CDC, about 37.3 million Americans are suffering from diabetes, covering about 11.3 % of the United States population. The increasing prevalence of lifestyle disorders is raising the health consciousness among consumers driving the need for sugar alternatives in North America, and positively impacting market growth.

Dynamics

Functional Benefits of Fructo-Oligosaccharides

Fructo-oligosaccharides are non-cariogenic, they are set to be used as soluble dietary fibers. They are good sources of soluble, dietary fiber and promote the reduction or elimination of constipation. They also support the growth of healthy bacteria in the digestive tract by suppressing toxic bacteria associated with food poisoning.

Fructo-oligosaccharides are non-digestible and travel intact through the small intestine to the colon, where they support the growth of healthy bacteria which help in maintaining proper digestive health. Fructo-oligosaccharides are used as an ingredient in prebiotic supplements. Fructo-oligosaccharides have beneficial physiological effects such as improved mineral absorption.

High Use of Fructo-Oligosaccharides as an Alternative Sugar

According to the World Health Organization 2022 statistics, more than 1 billion people globally are suffering from obesity, where 650 million people are adults and 340 million are adolescents. The severity of obesity is increasing in children too, accounting for up to 39 million according to 2022, WHO statistics.

According to IDF Diabetes Atlas 2021, 537 million adults are living with diabetes in the world. The organization reports that the prevalence is increasing rapidly and is estimated to reach 643 million by 2030. With the increasing prevalence of obesity and diabetes globally due to high-calorie consumption, there is a greater need for low-calorie, alternative sweeteners.

Fructo-oligosaccharides are used primarily as a low-calorie, alternative sweetener. They are delicate sweet flavor has low calories, and provide less than half the caloric value of sucrose. These fructooligosaccharides are non-digestible, so they don't affect blood sugar levels. These are used in various food applications as an alternative sugar driving market growth.

High Cost and Potential Side Effects of the Fructo-Oligosaccharides

The high cost of fructo-oligosaccharides can be one of the major restraining factors for global market growth. The lower yield, high production costs, complex purification and quality control are some of the factors that contribute to the high cost of the fructo-oligosaccharides. The price-sensitive end-users may take up other alternative less expensive sugar alternatives, leaving the product behind.

The overuse of fructo-oligosaccharides may cause some of the potential side effects such as diarrhea, bloating and stomach cramps. The side effects can also be due to the which can be fructose intolerance. The high use can lead to gastric distress and hurt people with irritable bowel syndrome.

Segment Analysis

The global fructo-oligosaccharides market is segmented based on source, form, application and region.

High Demand for Low-Calorie Food and Beverage Products

The global fructo-oligosaccharides market is segmented based on application into infant formulation, food & and beverages, dietary supplements, animal feed, and pharmaceuticals. Food and beverage accounted for the largest share of the global market due to increased demand for low-calorie food products. With the increasing health concerns related to high-sugar products, there is a surge in demand for sugar alternatives for their use in the production of low-calorie food and beverages.

The fructo-oligosaccharides have multiple applications in the food and beverage sectors such as confectionery, bakery, beverages, desserts and others. The new product launch for their application in the food and beverages sectors drives the segment growth. For instance, in May 2023, BENEO, the company that offers naturally sourced, functional ingredients announced the launch of Beneo-scL85 ingredients for sugar reduction. These ingredients are actively used in various food applications such as bakery, dairy, and cereals.

Geographical Penetration

Increasing Demand for Low-Calorie Products In North America

North America dominated the global fructo-oligosaccharides market. With the increasing health consciousness among consumers, there is a greater need for healthy alternatives for various food products in this region. The region has an increased prevalence of obesity and diabetes driving the need for alternative sugar products for its use in multiple food product manufacturing.

According to the Centers for Disease Control and Prevention 2023, obesity affects over 41.9 % of adults and 19.7 % of children in the United States. The American Heart Association recommends the strict restriction of less than 100 sugar calories per day for most adult women and less than 150 sugar calories per day for most men, motivating consumers to take low-calorie products, and increasing the demand for sugar alternatives.

Competitive Landscape

The major global players in the market include BENEO, Cargill, Incorporated, Ingredion, Tereos, Biosynth, Tate & Lyle, Galam Group, TATA Chemicals Limited, AVANSCHEM and Merck KGaA.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic had a positive impact on the global fructo-oligosaccharides market. Even though the pandemic created greater challenges for the market manufacturers in the production and distribution of the product to the end-user due to interrupted supply chain activities, the market then increased its sales through the use of e-commerce platforms and high demand from the end-use industries.

According to NIH 2020, obesity and diabetes are two major risk factors for COVID-19 hospitalization. The organization stated that people with diabetes mellitus and severe obesity are more likely to get infected and are at a higher risk of mortality from COVID-19. Among elderly patients who are at higher risk of death from COVID-19, 26.8% have diabetes mellitus. To maintain their calorie intake, increased consumer preference towards low-calorie products.

By Source

• Sucrose
• Inulin

By Form

• Liquid
• Powder

By Application

• Infant Formulation
• Food & Beverages
• Dietary Supplements
• Animal Feed
• Pharmaceuticals

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In May 2023, BENEO, the company that offers naturally sourced, functional ingredients announced the launch of Beneo-scL85 ingredients for sugar reduction. These ingredients are actively used in various food applications such as bakery, dairy, and cereals.
• In March 2022, Tate & Lyle PLC, a leading global provider of food and beverage ingredients and solutions, signed the agreement to acquire Quantum Hi-Tech Biological Co. Ltd, the company that is involved in the production and marketing of fructo-oligosaccharides.
• In June 2020, Galam, the global nutrition ingredients manufacturer of specialty ingredients for the food and animal nutrition industries, incorporated two new fructooligosaccharides production plants with an investment of about USD 20 million.

Why Purchase the Report?

• To visualize the global fructo-oligosaccharides market segmentation based on source, form, application and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of fructo-oligosaccharides market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global fructo-oligosaccharides market report would provide approximately 62 tables, 52 figures and 171 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Source
• 3.2. Snippet by Form
• 3.3. Snippet by Application
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Functional Benefits of Fructo-Oligosaccharides
    • 4.1.1.2. High Use as an Alternative Sugar
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost and Potential Side Effects of the Fructo-Oligosaccharides
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Source

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 7.1.2. Market Attractiveness Index, By Source
• 7.2. Sucrose
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Inulin

8. By Form

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 8.1.2. Market Attractiveness Index, By Form
• 8.2. Liquid
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Powder

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Infant Formulation
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Food & Beverages
• 9.4. Dietary Supplements
• 9.5. Animal Feed
• 9.6. Pharmaceuticals

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. BENEO
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Cargill, Incorporated
• 12.3. Ingredion
• 12.4. Tereos
• 12.5. Biosynth
• 12.6. Tate & Lyle
• 12.7. Galam Group
• 12.8. TATA Chemicals Limited
• 12.9. AVANSCHEM
• 12.10. Merck KGaA

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us